ORGO Organogenesis Holdings Inc.
Organogenesis Holdings Inc. (ORGO) is expected to report earnings on November 5, 2026, after the market close.
Sign in or subscribe to unlock sentiment, short interest, and technical indicators.
Whisperings™
About Organogenesis Holdings Inc.
Organogenesis Holdings Inc. is a leading regenerative medicine company offering a portfolio of bioactive and acellular biomaterials products in advanced wound care and surgical biologics, including orthopedics and spine. Organogenesis’s comprehensive portfolio is designed to treat a variety of patients with repair and regenerative needs.
Sector
Healthcare
Industry
Drug Manufacturers/Other